Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?

Background: Aromatase inhibitors (AI) are widely used for treating hormone-sensitive breast cancer (BC). Obesity, however, due to aromatase-mediated androgen conversion into estradiol in the peripheral adipose tissue, might impair AI inhibitory capacity. We aimed at identifying a cut-off of body mas...

Descripción completa

Detalles Bibliográficos
Autores principales: Riondino, Silvia, Formica, Vincenzo, Valenzi, Elena, Morelli, Cristina, Flaminio, Valeria, Portarena, Ilaria, Torino, Francesco, Roselli, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857850/
https://www.ncbi.nlm.nih.gov/pubmed/36661743
http://dx.doi.org/10.3390/curroncol30010094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857850/
https://www.ncbi.nlm.nih.gov/pubmed/36661743
http://dx.doi.org/10.3390/curroncol30010094

Ejemplares similares